View Older Stories View More Recent Stories

Jul 28, 2020 07:08AM CytoSorbents Announces the REFRESH 2-AKI Trial Data Monitoring Committee Has Recommended Study Resumption Following Favorable Review of Safety Data
Jul 28, 2020 06:00AM CytoSorbents to Report Q2 2020 Operating and Financial Results
Jul 20, 2020 04:57PM Cytosorbents (CTSO) Provides Q2 Financial Results, Corporate Update
Jul 20, 2020 04:51PM CytoSorbents Provides Preliminary Q2 2020 Financial Results and Corporate Update
Jun 29, 2020 07:08AM CytoSorbents to Host Key Opinion Leader Call on the Use of CytoSorb Blood Purification to Remove Antithrombotic Medications in Patients at Risk of Bleeding
Jun 29, 2020 07:08AM /C O R R E C T I O N -- CytoSorbents Corporation/
Jun 24, 2020 07:33AM Cytosorbents (CTSO) Announces Commercial Launch and Immediate Availability of CytoSorb To Treat Cytokine Storm In Many Latin American Countries
Jun 24, 2020 07:30AM CytoSorbents Announces Commercial Launch and Immediate Availability of CytoSorb To Treat Cytokine Storm In Many Latin American Countries As COVID-19 Cases Rise
Jun 9, 2020 07:08AM CytoSorbents Awarded $2,897,172 Phase III STTR Contract to Advance HemoDefend-BGA Plasma and Whole Blood Filter to Clinical Trials
May 27, 2020 12:00PM CytoSorbents Announces Virtual Annual Meeting
May 12, 2020 07:08AM CytoSorb® is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery
May 5, 2020 04:15PM CytoSorbents Reports First Quarter 2020 Financial and Operational Results
May 4, 2020 07:08AM CytoSorbents Promotes Vincent J. Capponi to President
Apr 29, 2020 07:00AM CytoSorbents Receives $1.1 Million in Non-Dilutive Funding from the New Jersey Business Tax Certificate Transfer Program
Apr 28, 2020 08:00AM CytoSorbents to Report Q1 2020 Operating and Financial Results
Apr 27, 2020 07:08AM Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
Apr 20, 2020 06:59AM Cytosorbents (CTSO) Announces FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery
Apr 20, 2020 06:58AM Development Update: U.S. FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery
Apr 15, 2020 07:03AM Cytosorbents (CTSO) Says New Study Suggests CytoSorb Improves Clinical Outcomes in Pneumonia Patients With Septic Shock and ARDS on ECMO
Apr 15, 2020 07:00AM New Study Suggests CytoSorb Improves Clinical Outcomes in Pneumonia Patients With Septic Shock and Acute Respiratory Distress Syndrome (ARDS) on ECMO
Apr 13, 2020 07:45AM Cytosorbents (CTSO) Announces U.S. FDA Grants it Emergency Use Authorization for Use in Patients with COVID-19 Infection
Apr 13, 2020 07:43AM U.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 Infection
Apr 3, 2020 12:07PM Cytosorbents (CTSO) CEO to Discuss COVID-19 Pandemic and its CytoSorb Treatment of Cytokine Storm
Apr 3, 2020 12:06PM CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today
Mar 31, 2020 07:08AM CytoSorb® Receives Marketing Approval in Mexico with Commercialization to Commence with Partner Fresenius Medical Care
Mar 25, 2020 07:34AM Cytosorbents (CTSO) Announces CytoSorb Used to Treat More than 70 Critically-Ill COVID-19 Patients and Specifically Added to Coronavirus Treatment Guidelines in Italy and Panama
Mar 25, 2020 07:19AM CytoSorb® Used to Treat More than 70 Critically-Ill COVID-19 Patients and Specifically Added to Coronavirus Treatment Guidelines in Italy and Panama
Mar 12, 2020 09:38AM Cytosorbents (CTSO) Provides Update on CytoSorb and COVID-19 Coronavirus Activities
Mar 12, 2020 09:33AM CytoSorbents Provides Update on CytoSorb and COVID-19 Coronavirus Activities
Mar 5, 2020 04:15PM CytoSorbents Announces 2019 Financial and Operational Results
Mar 2, 2020 07:00AM CytoSorbents Highlights Recent Publication Using CytoSorb during Cardiac Surgery for Infective Endocarditits
Feb 28, 2020 07:00AM CytoSorb Shipment Arrives in Designated Mainland China Hospitals to Treat Cytokine Storm in Critically-ill Patients with COVID-19 Coronavirus Infection
Feb 27, 2020 07:00AM CytoSorbents to Report Fiscal 2019 Operating and Financial Results and to Present at Cowen 40th Annual Healthcare Conference
Feb 19, 2020 07:00AM CytoSorbents Enters Agreement with China Medical System Holdings Limited to Bring CytoSorb to Mainland China to Treat Critically-ill Patients with COVID-19 Coronavirus Infection
Jan 29, 2020 07:45AM Cytosorbents (CTSO) Announces CytoSorb is Approved, Available for Removal of Ticagrelor During Cardiopulmonary Bypass in E.U.
Jan 29, 2020 07:25AM CytoSorb® is Approved and Available for the Removal of Ticagrelor, a Leading Anti-Platelet Drug, During Cardiopulmonary Bypass in the E.U.
Jan 28, 2020 07:09AM Cytosorbents (CTSO) Says CytoSorb Could Be Used for Coronavirus
Jan 28, 2020 07:01AM CytoSorb, the Wuhan Coronavirus, and Cytokine Storm
Jan 22, 2020 06:35AM Cytosorbents (CTSO) Treatment Improves Rat Survival Following Lethal Intravenous Dose of Fungal Aflatoxin
Jan 22, 2020 06:30AM CytoSorb Treatment Improves Rat Survival Following Lethal Intravenous Dose of Fungal Aflatoxin
Jan 14, 2020 09:33AM Cytosorbents (CTSO) Reports Preliminary 2019 Financial Results, Issues Stockholder Letter
Jan 14, 2020 09:30AM CytoSorbents Reports Preliminary 2019 Financial Results and Issues Stockholder Letter
Jan 7, 2020 10:13AM CytoSorbents to Present at Biotech Showcase™ 2020
Dec 2, 2019 07:45AM CytoSorbents to Present at the Piper Jaffray 31st Annual Healthcare Conference
Nov 25, 2019 07:04AM Cytosorbents (CTSO) temporarily pauses enrollment of its REFRESH 2-AKI study at the recommendation of DMC
Nov 25, 2019 07:00AM CytoSorbents Changes Contract Research Organizations and Temporarily Pauses Enrollment in REFRESH 2-AKI Study
Nov 19, 2019 07:00AM CytoSorbents to Present at the Three Part Advisors 2019 Southwest IDEAS Investor Conference
Nov 6, 2019 05:20PM Dr. Eric Mortensen to Leave CytoSorbents At Year End
Nov 5, 2019 04:15PM CytoSorbents Reports Third Quarter 2019 Financial Results
Nov 4, 2019 07:05AM CytoSorbents Announces Additions to its International Clinical Team
View More Recent Stories View Older Stories